Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,320,700 | 6,536,200 | 4,582,100 | 3,666,400 | 3,871,600 |
| Marketable Securities | 88,200 | 1,497,900 | 1,456,500 | 785,400 | 955,400 |
| Receivables | 5,776,800 | 5,262,200 | 4,766,300 | 4,071,600 | 3,801,300 |
| Inventories | 3,098,100 | 4,458,300 | 3,561,900 | 3,445,800 | 2,740,000 |
| Other current assets | 2,229,100 | 0 | 0 | 0 | 0 |
| TOTAL | $20,549,600 | $19,202,100 | $15,101,400 | $12,573,600 | $11,928,300 |
| Non-Current Assets | |||||
| PPE Net | 7,996,100 | 8,826,500 | 8,252,600 | 8,053,500 | 7,963,900 |
| Investments And Advances | 2,005,400 | 5,678,800 | 5,207,500 | 3,646,600 | 4,568,900 |
| Intangibles | 1,068,000 | 4,029,200 | 4,357,900 | 5,034,800 | 2,884,200 |
| Other Non-Current Assets | 12,289,300 | 7,244,400 | 5,886,500 | 6,260,400 | 8,962,300 |
| TOTAL | $23,358,800 | $25,778,900 | $23,704,500 | $22,995,300 | $24,379,300 |
| Total Assets | $43,908,400 | $44,981,000 | $38,805,900 | $35,568,900 | $36,307,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,207,100 | 1,410,700 | 1,349,300 | 1,338,200 | 1,128,100 |
| Other current liabilities | 7,841,800 | 8,295,100 | 7,032,700 | 5,987,400 | 5,300,400 |
| TOTAL | $11,888,100 | $14,535,900 | $10,986,600 | $8,229,600 | $9,741,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,196,400 | 9,940,500 | 8,367,800 | 7,972,400 | 5,332,800 |
| Other Non-Current Liabilities | 10,602,100 | 8,836,700 | 5,371,000 | 4,776,600 | 5,845,700 |
| TOTAL | $21,111,200 | $18,777,200 | $13,738,800 | $12,749,000 | $11,178,500 |
| Total Liabilities | $32,999,300 | $33,313,100 | $24,725,400 | $20,978,600 | $20,919,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,035,419 | 1,095,598 | 1,103,352 | 1,106,093 | 1,111,104 |
| Common Shares | 661,000 | 687,900 | 688,500 | 691,300 | 694,600 |
| Retained earnings | 11,395,900 | 13,894,100 | 16,046,300 | 16,011,800 | 16,482,700 |
| Other shareholders' equity | -7,662,400 | -8,655,900 | -8,213,900 | -7,574,900 | -6,990,500 |
| TOTAL | $10,909,100 | $11,667,900 | $14,080,500 | $14,590,300 | $15,388,100 |
| Total Liabilities And Equity | $43,908,400 | $44,981,000 | $38,805,900 | $35,568,900 | $36,307,600 |